Russell Frank Company’s West Pharmaceutical WST Stock Holding History

Russell Frank Company’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$42K	Hold	604	–	–	﹤0.01%	2884
2015 Q4	$37K	Hold	604	–	–	﹤0.01%	2912
2015 Q3	$33K	Sell	604 -302	-33%	-$17.6K	﹤0.01%	2941
2015 Q2	$53K	Buy	906 +604	+200%	+$33.7K	﹤0.01%	2958
2015 Q1	$18K	Buy	+302	New	+$16.1K	﹤0.01%	2904
2014 Q4	–	Sell	-107,289	Closed	-$4.8M	–	3038
2014 Q3	$4.8M	Buy	107,289 +88,998	+487%	+$3.78M	0.01%	1312
2014 Q2	$747K	Buy	18,291 +1,181	+7%	+$50.6K	﹤0.01%	2187
2014 Q1	$754K	Sell	17,110 -47,008	-73%	-$2.21M	﹤0.01%	2215
2013 Q4	$3.14M	Buy	64,118 +13,650	+27%	+$639K	0.01%	1489
2013 Q3	$2.08M	Sell	50,468 -3,066	-6%	-$117K	﹤0.01%	1841
2013 Q2	$1.88M	Buy	+53,534	New	+$1.76M	﹤0.01%	1797

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Russell Frank Company's WST Position: Q1 2016 in Review

Russell Frank Company held its West Pharmaceutical (WST) position steady in Q1 2016 at 604 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

Russell Frank Company first reported a position in WST in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.8M in Q3 2014. 250 funds tracked by Wall St. Rank hold WST as of Q1 2016.

Russell Frank Company held 604 shares of West Pharmaceutical worth $42K as of Q1 2016.
Russell Frank Company left its West Pharmaceutical share count unchanged in Q1 2016.
West Pharmaceutical made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2884 holding.
Russell Frank Company first reported a position in West Pharmaceutical in Q2 2013 and has held it in 11 quarters since.
Russell Frank Company's West Pharmaceutical position peaked at $4.8M in Q3 2014.
250 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.